The Magnum Ice Cream Company N.V.
Director/PDMR Shareholding
Director/PDMR Shareholding
The Magnum Ice Cream Company N.V.
(TMICC or the Company)
NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS) AND THEIR PERSONS CLOSELY ASSOCIATED (PCA)
The Company notifies the following change in interests in the ordinary shares of EUR3.50 each (Shares) of PDMRs, arising pursuant to acquisitions and the Admission of TMICC to listing on Euronext Amsterdam, the London Stock Exchange and the New York Stock Exchange.
| Directors | Number of Shares |
| Jean François van Boxmeer | 7,800 |
| Melissa Bethell | 7,750 |
| René Hooft Graafland | 20,000 |
| Other PDMRs | |
| Tim Gunning | 15,800 |
This announcement is made in accordance with the requirements of the EU and UK version of the Market Abuse Regulation 596/2014.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name of natural person | Jean François van Boxmeer | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Board Chair | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | The Magnum Ice Cream Company N.V. | ||||
| b) | Legal Entity Identifier code | 25490052LLF3XH6G9847 | ||||
| 4 | Details of the transaction(s) summary table | |||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | ||
| 8-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | ||
| Nature of Transaction | | Price | Volume | Total | ||
| Acquisition | 12.8430 | 7,800 | 100,175.40 | |||
| Aggregated | 12.8430 | 7,800 | 100,175.40 | |||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||
| a) | Name of natural person | Melissa Bethell | |||||
| 2 | Reason for the notification | ||||||
| a) | Position/status | Non-Executive Director | |||||
| b) | Initial notification/Amendment | Initial notification | |||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
| a) | Name | The Magnum Ice Cream Company N.V. | |||||
| b) | Legal Entity Identifier code | 25490052LLF3XH6G9847 | |||||
| 4 | Details of the transaction(s) summary table | ||||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | |||
| 9-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | |||
| Nature of Transaction | | Price | Volume | Total | |||
| Acquisition | 12.4785 | 4,000 | 49,914.00 | ||||
| Aggregated | 12.4785 | 4,000 | 49,914.00 | ||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | |||
| 10-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | |||
| Nature of Transaction | | Price | Volume | Total | |||
| Acquisition | 12.371 | 3,750 | 46,391.25 | ||||
| Aggregated | 12.371 | 3,750 | 46,391.25 | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||||
| a) | Name of natural person | René Hooft Graafland | ||||||||||
| 2 | Reason for the notification | |||||||||||
| a) | Position/status | Non-Executive Director | ||||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||
| a) | Name | The Magnum Ice Cream Company N.V. | ||||||||||
| b) | Legal Entity Identifier code | 25490052LLF3XH6G9847 | ||||||||||
| 4 | Details of the transaction(s) summary table | |||||||||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | ||||||||
| 9-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | ||||||||
| Nature of Transaction | | Price | Volume | Total | ||||||||
| Acquisition | 12.50 | 20,000 | 250,000 | |||||||||
| Aggregated | 12.50 | 20,000 | 250,000 | |||||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||||
| a) | Name of natural person | Tim Gunning | ||||||||||
| 2 | Reason for the notification | |||||||||||
| a) | Position/status | Chief of Staff & Head of Strategy | ||||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||
| a) | Name | The Magnum Ice Cream Company N.V. | ||||||||||
| b) | Legal Entity Identifier code | 25490052LLF3XH6G9847 | ||||||||||
| 4 | Details of the transaction(s) summary table | |||||||||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | ||||||||
| 8-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | ||||||||
| Nature of Transaction | | Price | Volume | Total | ||||||||
| Acquisition | 12.7375 | 15,000 | 191,062.96 | |||||||||
| Aggregated | 12.7375 | 15,000 | 191,062.96 | |||||||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | ||||||||
| 9-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | EUR | ||||||||
| Nature of Transaction | | Price | Volume | Total | ||||||||
| Acquisition | 12.50 | 800 | 10,000 | |||||||||
| Aggregated | 12.50 | 800 | 10,000 | |||||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name of natural person | Dorothee ter Kulve (Spouse of Peter ter Kulve) | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Spouse of Chief Executive Officer | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | The Magnum Ice Cream Company N.V. | ||||
| b) | Legal Entity Identifier code | 25490052LLF3XH6G9847 | ||||
| 4 | Details of the transaction(s) summary table | |||||
| Date of Transaction | Description of Instrument | Identification Code | Place of Transaction | Currency | ||
| 8-DEC-2025 | Ordinary shares of €3.50 each | ISIN: NL0015002MS2 | Amsterdam Stock Exchange - XAMS | GBP | ||
| Nature of Transaction | | Price | Volume | Total | ||
| Demerger Shares | n/a | 1,938 | n/a | |||
| Aggregated | n/a | 1,938 | n/a | |||
| Enquiries | |
| Media Relations media.relations-tmicc@magnumicecream.com | Investor Relations investor.relations-tmicc@magnumicecream.com |
About The Magnum Ice Cream Company
The Magnum Ice Cream Company is the world’s largest ice cream company. With an unrivalled portfolio of brands including global power brands Magnum, Ben & Jerry’s, Wall’s and Cornetto, and with a global fleet of nearly 3 million freezers, our products are available in 80 countries. The company generated €7.9 billion in revenue in 2024. TMICC’s legal entity identifier is 25490052LLF3XH6G9847. For more information, visit The Magnum Ice Cream Company website.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ProMIS Neurosciences Inc.10.12.2025 13:30:00 CET | Press release
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
Tallink Grupp10.12.2025 13:30:00 CET | Press release
AS Tallink Grupp: Managers’ Transactions
Scatec ASA10.12.2025 13:26:22 CET | Press release
Scatec starts commercial operation at Mmadinare phase 2 in Botswana
Karolinska Development AB (publ)10.12.2025 13:05:37 CET | Press release
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia
Nykredit Realkredit A/S10.12.2025 12:51:58 CET | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom